The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,868.00
Bid: 1,854.00
Ask: 1,860.00
Change: 0.00 (0.00%)
Spread: 6.00 (0.324%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,868.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Porcine Multiplication Agreement in China

3 Sep 2014 07:00

RNS Number : 6735Q
Genus PLC
03 September 2014
 



For immediate release

3 September 2014

 

Genus plc

('Genus' or the 'Group')

 

Strategic Porcine Multiplication Agreement in China

 

3 September 2014 - Genus plc (LSE: GNS), a leading global animal genetics company, is pleased to announce a new strategic agreement with River Stone Farm (Shandong) Co., Ltd ('Riverstone') to become the Group's first commercial multiplier in China. Riverstone is a joint venture between Black River Capital Partners Food Fund Holdings (Singapore) Pte Ltd ('Black River') and Pipestone System, a leading US pig management company. Under the terms of the multi-year agreement, Genus's porcine genetics division, Genus PIC, will exclusively stock and sustain Riverstone's new pig production project in China, with a total anticipated herd size of 24,000 sows.

 

China is the largest pork market worldwide and the agreement with Riverstone positions Genus for additional growth by providing significant new capacity without material upfront investment and with lower commodity risk exposure. It also enables the Group to develop its royalty revenue model in China, providing resilient revenue streams.

 

Riverstone's project comprises four breeding farms based in Shandong, eastern China, capable of producing in total more than 600,000 pigs for market every year. The first module of 6,200 pigs will be ready for stocking in the first quarter of 2015 and will produce grandparent and parent gilts for both Genus and Riverstone as well as supplying the market with prime slaughter pigs. As a result of the agreement, Genus will be able to access more than 10,000 grandparent gilts a year for sale to large-scale integrated producers.

 

The project also features a dedicated artificial insemination stud to house sire line boars for commercial pig production and dam line males for great-grandparent and grandparent matings. The genetic profile of the herd will be monitored and managed using Genus PIC's proprietary software and database to maximise the effectiveness of the genetic improvement programme. The database is the largest of its kind with tens of millions of pedigree, performance and genomic data points supporting accelerated genetic progress.

 

Karim Bitar, CEO of Genus, said,

 

"As the largest market for pork globally, we continue to see long-term growth potential in China. We are seeking to build capacity in the country, whilst reducing the upfront investment and exposure to commodity risk, and this first commercial multiplication partnership represents an important milestone in this strategy. We look forward to working with Riverstone to help provide Chinese consumers with safe, affordable and high quality pork."

 

Commenting on the agreement, Wei Guo, Director of Riverstone, said,

 

"Genus represents the industry leader in porcine genetics and we are excited to be working with Genus in order to achieve the growth opportunities in China. Riverstone's aim is to produce safe pork in an efficient and environmentally-friendly way. Partnering with Genus will enable us to focus on our commercial production to achieve this aim."  

 

For further information please contact:

 

Genus plc

Tel: 01256 345970

Karim Bitar, Chief Executive

Stephen Wilson, Group Finance Director

 

Buchanan

 

Tel: 0207 466 5000

Charles Ryland / Sophie McNulty

 

This announcement is available on the Genus website www.genusplc.com

 

 

-Ends-

 

About Genus

Genus creates advances to animal breeding and genetic improvement by applying biotechnology and sells added value products for livestock farming and food producers. Its technology is applicable across all livestock species and is currently commercialised by Genus in the dairy, beef and pork food production sectors.

 

Genus's worldwide sales are made in seventy countries under the trademarks 'ABS' (dairy and beef cattle) and 'PIC' (pigs) and comprise semen and breeding animals with superior genetics to those animals currently in production. Genus's customers' animals produce offspring with greater production efficiency, and quality, and use these to supply the global dairy and meat supply chain.

 

The Group's competitive edge has been created from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and its global supply chain, technical service and sales and distribution network.

www.genusplc.com 

 

About Pipestone System

Pipestone System manages 170,000 sows on 40 production units in Minnesota, Iowa, Nebraska and South Dakota. In China, Pipestone already has management contracts with integrators Besun (a Genus PIC joint venture partner) and Shennong.

www.pipestonesystem.com 

 

About Black River

Black River is a wholly owned subsidiary of Black River Capital Partners Fund (Food) LP, which is a private equity fund managed by Black River Asset Management LLC ('BRAM'). BRAM is a global asset management firm specialising in alternative investment strategies. Formed in 2003, it is an independently managed subsidiary of Cargill, Inc., a privately held corporation and one of the world's leading suppliers of food, agricultural and industrial products and services. BRAM's investment professionals are located in 12 countries spanning five continents.

www.black-river.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRBRGDCDGGBGSD
Date   Source Headline
1st May 20241:59 pmRNSTotal Voting Rights
22nd Feb 20247:00 amRNSInterim Results
15th Feb 20247:00 amRNSTrading Update
1st Feb 20244:24 pmRNSBlock listing Interim Review
1st Feb 20244:21 pmRNSTotal Voting Rights
12th Dec 20237:00 amRNSNon-Executive Director Appointment
22nd Nov 20231:08 pmRNSResult of AGM
22nd Nov 20237:00 amRNSAGM Trading Update
1st Nov 20234:46 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSCapital Markets Event
13th Oct 20237:00 amRNSAnnual Report and Annual General Meeting
5th Oct 202310:19 amRNSPos. determination-PRRS resistant pigs-Colombia
2nd Oct 202311:12 amRNSTotal Voting Rights
15th Sep 20231:07 pmRNSDirector/PDMR Shareholding
15th Sep 202310:04 amRNSDirector/PDMR Shareholding
7th Sep 20237:00 amRNSPreliminary Results
25th Aug 20238:35 amRNSNotification of Major Holdings
23rd Aug 20239:25 amRNSDirectorate Change
1st Aug 202311:41 amRNSBlock listing Interim Review
1st Aug 202311:36 amRNSTotal Voting Rights
3rd Jul 202311:02 amRNSTotal Voting Rights
16th Jun 20235:33 pmRNSNational Milk Records plc - Form 8.3
16th Jun 20235:10 pmRNSForm 8.3 (OPD) - National Milk Records plc
8th Jun 20233:51 pmRNSDirector/PDMR Shareholding
7th Jun 20235:11 pmRNSNotification of Major Holdings
7th Jun 20235:08 pmRNSNotification of Major Holdings
5th Jun 20239:12 amRNSAdditional Listing
24th May 20234:54 pmRNSNotification of Major Holdings
18th May 20231:32 pmRNSDirector/PDMR Shareholding
16th May 20236:16 pmRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSTrading Update
9th May 20234:30 pmRNSNotification of Major Holdings
3rd May 20238:44 amRNSTotal Voting Rights
2nd May 20237:00 amRNSShare Award for Incoming CEO
3rd Apr 202311:27 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSAppointment of Chief Executive Officer Designate
21st Mar 20232:58 pmRNSApplication for Block Listing
6th Mar 202312:53 pmRNSNotification of Major Holdings
2nd Mar 20231:51 pmRNSNotification of Major Holdings
1st Mar 20232:20 pmRNSNotification of Major Holdings
24th Feb 20235:13 pmRNSDirector/PDMR Shareholding
24th Feb 202311:39 amRNSNotification of Major Holdings
23rd Feb 20239:33 amRNSReplacement: Interim Results
23rd Feb 20237:00 amRNSChief Executive Officer Retirement
23rd Feb 20237:00 amRNSInterim Results
21st Feb 20235:03 pmRNSNotification of Major Holdings
10th Feb 20232:08 pmRNSNotification of Major Holdings
1st Feb 202310:00 amRNSBlock listing Interim Review
23rd Nov 20221:02 pmRNSResult of AGM
23rd Nov 20227:00 amRNSAGM Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.